Pharmaceutical firms' patent strategies deter competition, says EU inquiry report
This article was originally published in Scrip
Executive Summary
"Originator companies have designed and implemented patent strategies aimed at hindering their competitors and thereby ensuring continued revenue streams for their medicines," Neelie Kroes, the EU's competition commissioner, told a conference in Brussels this morning on the inquiry into competition in the pharmaceutical sector.